The balance between IL17 expected role in protective immunity to HCV and its demonstrated role in inducing autoimmunity has to be further studied in MC and NHL HCV-positive patients to bring new insights into the pathogenesis of these disorders. The gene discussed is IL17A; the disease is non-Hodgkin lymphoma.